Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ralpha1)
Details for Australian Patent Application No. 2003212102 (hide)
International Classifications
Event Publications
24 July 2003 Complete Application Filed
Priority application(s): 2003900437 03.02.03 AU; PS 1301 22.03.02 AU
13 November 2003 Application Open to Public Inspection
Published as AU-B-2003212102
16 July 2009 Alteration of Name
The name of the applicant has been altered to Zenyth Operations Pty Ltd
24 September 2009 Section 223 Application Allowed
Zenyth Operations Pty Ltd The time in which to comply with Section 6(c) has been extended to 01 Jan 2004. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000 2004
14 January 2010 Application Accepted
Published as AU-B-2003212102
13 May 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003212101-Therapeutic ion channel blocking agents and methods of use thereof
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser